Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
ALCAM - Novel multiple sclerosis locus interfering with HLA-DRB1*1501.
[Compensatory mechanisms in multiple sclerosis(review)].
Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
Advances in the management of MS symptoms: real-life evidence.
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
DSM-III disorders from age 11 to age 15 years.
Targeting of aquaporin 4 into lipid rafts and its biological significance.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
IgGs containing λ- and κ-type light chains and of all subclasses (IgG1-IgG4) from the sera of patients with autoimmune diseases and viral and bacterial infections hydrolyze DNA.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
Prospective Evaluation of Laparoscopic Assisted Cystectomy and Ileal Conduit in Advanced Multiple Sclerosis.
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies.
Work-related problems in multiple sclerosis: a literature review on its associates and determinants.
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Multiple sclerosis severity score in a cohort of Moroccan patients.
Pages
« first
‹ previous
…
339
340
341
342
343
344
345
346
347
…
next ›
last »